To investigate whether coexistence of various neurodegenerative disorders is coincidental or biologically connected.
Introduction
It is not uncommon to see cases of neurodegeneration in clinical practice showing temporal development of one neurodegenerative disorder after another. For instance, observational studies have shown higher risk of Parkinson's disease (PD) and Alzheimers' disease (AD) among patients with a diagnosis of neovascular age-related macular degeneration (AMD) [1] [2] [3] [4] .
Occasional case reports of co-existence of Multiple sclerosis (MS) with Alzheimer's disease (AD) have also emerged in the literature 5 . Furthermore, the co-existence of Amyotrophic lateral sclerosis (ALS) with Frontotemporal dementia (FTD) had recently lead to revises consensus criteria for the diagnosis of FTD in ALS 6 .
Not surprisingly, most neurodegenerative diseases share certain clinical and pathological features. Furthermore, a number of genetic studies have time and again have also shown existence of shared genetic aetiology 7-9 . It is common to see overlapping symptoms among various neurodegenerative disorders. For instance, up to 50% of AD cases exhibit aggregation of alpha-synuclein into Lewy bodies, a characteristic seen in PD cases 10 . Furthermore, degeneration of retinal layer, a characteristic of AMD has also been reported in cases with ALS and MS 11, 12 . Of all the co-existing neurodegenerative, presence of ALS, parkinsonism and dementia together is the most well characterized combination often reported in specific geographic locations and known by several name such as kii-ALS or Guam-ALS or ALS-PDC 13, 14 .
It has been long debated whether co-existence of neurodegenerative disorders is purely coincidental or there is a causal relationship in between them. However, the varying latent phases of different neurodegenerative disorders make it difficult to interpret the exact relationship between the co-existing disorders. With age as a major confounding factor in observational studies, Mendelian randomization (MR) methodology could provide an alternative solution by providing life-long effect estimates using genetic variants as proxy pseudorandomized markers of neurodegenerative diseases 15 . Henceforth, the objective of the current study was to explore the causal relationships among different neurodegenerative disorders using MR approach.
Methods
A two-sample MR approach was applied to explore the relationship among six most commonly occurring neurodegenerative disorders namely Alzheimer's disease (AD), Amyotrophic lateral sclerosis (ALS), Age-related macular degeneration (AMD), Frontotemporal dementia (FTD), Multiple sclerosis (MS) and Parkinson's disease (PD) [16] [17] [18] [19] [20] . I employed latest available summary GWAS datasets for the present study to prioritize genetic instruments for each of the neurodegenerative disorder. I used inverse variance weighted method as the main method to generate unconfounded estimates using the summary statistics from respective GWAS datasets to explore the relationship between each pair of neurodegenerative disorder. A Bonferroni corrected threshold of P=0.005 (as ten pairs of neurodegernative disorders were compared) was considered to be significant, and P<0.05 was considered suggestive of evidence for a potential association. I also generated causal estimates adjusted for presence of potential pleiotropic variants by employing additional MR methods. The heterogeneity in the effect estimates were judged using MR-Egger, I2 and Cochrane-Q statistics. Lastly, sensitivity analysis was conducted to check reliability of estimates by excluding variants known to be directly involved in specific neurodegenerative disorder as an outcome, and variants believed to be potential confounders between pair of neurodegenerative disorder under consideration.
Results
All the datasets used in the study have been shown in Table 1 . In addition, complete summary statistics used for causal analysis is provided in Supplementary table 1. The results from direct and reverse causal estimate analysis have been provided in Table 2a to 2e. I observed a risky effect of PD on ALS (OR = 1.126, 95% CI = 1.059-1.198, P = 0.005). The risky effect was further retained using IVW, MR-Egger and WME method. Furthermore, a weak bidirectional relationship was observed between AD and PD. Using AD as exposure and PD as outcome, I observed a risky effect of AD on PD using all the MR methods with strongest results using MBE method (OR = 2.072, 95% CI = 1.006-4.028, P = 0.0416). A moderate risky effect of PD on AD was further observed using WME method (OR = 1.013, 95% CI = 1.006-1.019, P = 0.0606).
Genetic predisposition to AD was further observed to be a risky for AMD (OR = 1.759, 95% CI = 1.040-1.974, P = 0.0363). On the contrary, AMD was observed to be strongly protective towards MS using MR-Egger method in the presence of significant pleiotropy (MR-Egger intercept p-value = 0.0481, OR = 0.861, 95% CI = 0.776-0.955, P = 0.0059).
Discussion
The present study is the first study to comprehensively explore causal relationship among various neurodegenerative disorders. My results strongly confirm the genetic relationship between PD, ALS and PD as observed in the case of patients with kii-ALS or Guam-ALS or ALS-PDC. My results further suggest risky and protective effect of AMD towards AD and MS which is consistence with the relative prevalence of retinal degeneration seen in cases of AD and MS (See Supplementary table 2) .
My study has several strengths and limitations. It is one of the most comprehensive study exploiting the genetics of neurodegenerative disorders to understand the relationship among different disorders. However, differential genomic coverage and different sample sizes of different datasets make it difficult to compare the results. It is quite possible that healthy controls used in different GWAS datasets may be overlapping, leading to the risk of bias in the findings. Nevertheless, I used improved version of IVW method which takes care of these biases. Another limitation could be my inability to explore causality using different types of dementias including Frontotemporal dementia (FTD) which is known to occur in combination with ALS, as it was observed that FTD dataset was highly underpowered with sample size <5000 individuals.
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